Top Buy
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Resmed Inc. | 19 | 0 | 3 | 0 | €198.95 | €203.18 | 2.125% |
| Centene Corp. | 15 | 0 | 3 | 0 | €72.22 | €82.57 | 14.332% |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 3 | 0 | €76.16 | €102.62 | 34.741% |
| Krystal Biotech | 17 | 0 | 3 | 0 | €145.65 | €179.60 | 23.306% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €363.70 | €421.61 | 15.921% |
| Edwards Lifesciences Corp. | 26 | 1 | 3 | 0 | €79.88 | €88.14 | 10.338% |
| XOMA Corp. | 6 | 0 | 3 | 0 | €21.80 | €68.78 | 215.501% |
| United Therapeutics | 18 | 0 | 3 | 0 | €245.40 | €288.66 | 17.629% |
| EyePoint Pharmaceuticals Inc. | 17 | 1 | 3 | 0 | €11.22 | €27.83 | 148.159% |
| Pacira Pharmaceuticals | 18 | 0 | 3 | 0 | €27.00 | €47.53 | 76.030% |
| Humana Inc. | 23 | 0 | 3 | 0 | €310.20 | €439.88 | 41.804% |
| Heron Therapeutics Inc. | 10 | 1 | 3 | 0 | €2.58 | €4.58 | 77.679% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €19.85 | €26.01 | 31.048% |
| Select Medical Holdings | 6 | 0 | 3 | 0 | €31.40 | €36.41 | 15.944% |
| Twist Bioscience Corp | 7 | 0 | 3 | 0 | €39.34 | €41.41 | 5.259% |
| Insulet Corp. | 16 | 0 | 3 | 0 | €155.40 | €215.54 | 38.698% |
| Halozyme Therapeutics Inc. | 14 | 0 | 3 | 0 | €40.06 | €50.33 | 25.643% |
| Cytokinetics Inc. | 26 | 1 | 3 | 0 | €59.00 | €84.57 | 43.342% |
| Johnson & Johnson | 32 | 1 | 3 | 0 | €139.46 | €196.74 | 41.070% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | €38.00 | €84.74 | 123.011% |
| Alnylam Pharmace. | 36 | 0 | 3 | 0 | €138.75 | €236.30 | 70.305% |
| Pfizer Inc. | 31 | 4 | 3 | 0 | €25.97 | €41.10 | 58.302% |
| Addus Homecare Corp. | 15 | 1 | 4 | 1 | €97.00 | €103.07 | 6.258% |
| Hologic Inc. | 17 | 0 | 4 | 0 | €70.00 | €84.52 | 20.744% |
| Thermo Fisher Scientific Inc. | 26 | 0 | 4 | 0 | €552.90 | €568.09 | 2.748% |